Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Preston

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoitesSeif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
Malaria Journal|March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial GuineaMaxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian AdultsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
Malaria Journal|July 21, 2021
Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial GuineaVicente Urbano Nsue Ndong Nchama, Ali Hamad Said, Ali Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoitesSeif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
Malaria Journal|March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial GuineaMaxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian AdultsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
Nature|July 1, 2021
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunityAgnes Mwakingwe-Omari, Sara A Healy, Jacquelyn Lane, et al.
Malaria Journal|July 21, 2021
Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial GuineaVicente Urbano Nsue Ndong Nchama, Ali Hamad Said, Ali Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|November 18, 2020
Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean AdultsSaid A Jongo, Vicente Urbano, L W Preston Church, et al.
Pageof 4